MAV Korhaz és Rendelointezet
About MAV Korhaz és Rendelointezet
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
3
R-Pharm International, LLC
3
Janssen Research & Development, LLC
2
Pfizer
2
Janssen Pharmaceutica N.V., Belgium
1
Sandoz
1
Clinical Trials at MAV Korhaz és Rendelointezet
During the past decade, MAV Korhaz és Rendelointezet conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on
average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
2007-11-01
2011-11-01
Completed
1,457
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
2010-01-01
2013-03-01
Completed
956
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-06-02
2016-10-27
Completed
504
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
2010-12-09
2017-08-16
Completed
529
Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
2013-09-04
2016-11-17
Completed
219
GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®
2015-07-01
2016-10-01
Completed
107
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease
2017-01-09
2019-10-01
Completed
368
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MAV Korhaz és Rendelointezet" #1 sponsor was "Amgen" with 3 trials, followed by "R-Pharm International, LLC" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Janssen Pharmaceutica N.V., Belgium"
with 2 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MAV Korhaz és Rendelointezet"
#1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at MAV Korhaz és Rendelointezet
According to Clinical.Site data, the most researched conditions in "MAV Korhaz és Rendelointezet" are
"Rheumatoid Arthritis" (4 trials), "Psoriatic Arthritis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "MAV Korhaz és Rendelointezet" in a lesser frequency.
Clinical Trials Intervention Types at MAV Korhaz és Rendelointezet
Most popular intervention types in "MAV Korhaz és Rendelointezet" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Adalimumab 40mg q2w" (1 trials) and "Apremilast 30 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MAV Korhaz és Rendelointezet
The vast majority of trials in "MAV Korhaz és Rendelointezet" are
12 trials for "All" genders.
Clinical Trials Status at MAV Korhaz és Rendelointezet
Currently, there are NaN active trials in "MAV Korhaz és Rendelointezet".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in MAV Korhaz és Rendelointezet,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MAV Korhaz és Rendelointezet, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of MAV Korhaz és Rendelointezet
MAV Korhaz és Rendelointezet has several departments that took part in Clinical trials: "MAV Korhaz es Rendelointezet, Reumatologiai szakrendeles" - 2 trials
Departments List
Name
City
Trials